D

DaVita
D

DVA

168.390
USD
-1.58
(-0.93%)
Market Closed
Volume
13,659
EPS
11
Div Yield
-
P/E
18
Market Cap
13,812,021,360
Related Instruments
    ABT
    ABT
    0.970
    (0.83%)
    117.780 USD
    C
    CHE
    -8.84
    (-1.58%)
    550.90 USD
    CNC
    CNC
    -0.130
    (-0.20%)
    63.540 USD
    H
    HSIC
    0.630
    (0.85%)
    74.800 USD
    M
    MMSI
    0.430
    (0.41%)
    104.830 USD
    S
    SRDX
    -0.430
    (-1.15%)
    37.090 USD
    T
    THO
    -1.380
    (-1.33%)
    102.250 USD
    U
    USPH
    0.240
    (0.27%)
    90.370 USD
    More
News

Title: DaVita

Sector: Healthcare
Industry: Medical Care Facilities
DaVita is the largest provider of dialysis services in the United States, boasting market share that eclipses 35% when measured by both patients and clinics. The firm operates over 3,000 facilities worldwide, mostly in the us, and treats about 250,000 patients globally each year. Government payers dominate us dialysis reimbursement. DaVita receives about two thirds of us sales at government (primarily Medicare) reimbursement rates, with the remainder coming from commercial insurers. While commercial insurers represent only about 10% of the us patients treated, they represent nearly all of the profits generated by DaVita in the us dialysis business.
Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Arincen would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Arincen and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Arincen and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Arincen may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.